Opinions Lorne Steinberg
Corteva Inc.CTVABUYJul 28, 2021
Crop science company, competing with Monsanto but without the social issues. Phenomenal R&D. Unique products. Huge impact in emerging markets. Helps with food security. Very well run, great cashflow generator, pretty good earnings growth. His pick in the sector.
Lorne SteinbergUnknown
$42.85
Stock price when the opinion was issued
$77.03
As of Jun 05, 2026. Market Open.
0
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
You might be interested:
PAST TOP PICK
(A Top Pick Aug 04/23, Down 3%)
Phenomenal business. Somewhat sensitive to corn prices. Back to a double-digit grower. Rock-solid balance sheet and free cashflow. Unique and great.
Lorne SteinbergOwned
0
TOP PICK
Seed & crop protection company.
Strong demand for agriculture products.
Double digit earnings growth.
Pristine balance sheet with little debt.
Steady dividend that is reliable.
Well run business with excellent management.
Lorne SteinbergOwned
0
BUY ON WEAKNESS
They make seeds and pesticides for agriculture, a sector which boomed this year. Corteva sales jumped this year, but will continue in years ahead. This isn't a fertilizer play (which is a trade, not investment). Farmers are and will buy Corteva's genetically modified seeds for the long-term. Despite its good run, CTVA still trades under 19x forward earnings.
Unspecified
It is probably the only crop protection and seeds business that is publicly traded. We need more productive seeds and chemicals in the agricultural business. There is a very low supplies to use ratio. The tight global grain market is due to the Ukraine/Russia conflict so Cortiva is important to the solution of the problem.
BUY
Necessary for food production in times of climate change. Management's done a great job, evolving their portfolio into higher margin businesses and products. Almost a tech company.
Lorne SteinbergOwned
0
BUY
Was spun off from the Dow-Dupont merger. We're seeing a bull market in the fertilizer market. Corteva's genetically modified seeds produce the best yields in the business. A JPMorgan reports forecasts low agricultural yields and higher demand short-term.
BUY
NTR vs. Corteva He owns both. Cortevais into crop protection. Nutrien is in fertilizer. Both are strongly correlated to commodity prices, however. Nutrien pays a healthy dividend, but Corteva offers better growth and could benefit from ongoing climate change problems. Both are best-in-class businesses.
Lorne SteinbergOwned
0
TOP PICK
They don’t have the Monsanto issues. People don’t want to buy GMO foods but the fact is that it is how we feed places like India and China where people used to die of starvation when there were droughts. He expects earnings growth of 15% for the next few years. It will get better over the next few years. (Analysts’ price target is $32.81)
Lorne SteinbergOwned
0
